Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials

AB Kunnumakkara, M Hegde, D Parama… - ACS Pharmacology & …, 2023 - ACS Publications
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …

Curcumin for the treatment of COVID‐19 patients: a meta‐analysis of randomized controlled trials

A Shafiee, MMT Athar, A Shahid… - Phytotherapy …, 2023 - Wiley Online Library
Curcumin is a low‐cost and easily accessible therapeutic option for COVID‐19 patients. We
aimed to conduct a meta‐analysis to assess the effect of curcumin on clinical outcomes in …

The efficacy of herbs as Complementary and Alternative Therapy in recovery and clinical outcome among people with COVID-19: a systematic review, meta-analysis …

M Komariah, S Amirah, S Maulana… - … and Clinical Risk …, 2023 - Taylor & Francis
Background The COVID-19 pandemic continues, and this condition has caused many cases
in various countries around the world, resulting in more than 6 million deaths worldwide …

Use of traditional and complementary medicine for COVID 19 prophylaxis among healthcare professionals and students in Jordan: A cross-sectional study

N Bulatova, S Younes, M Arabiyat, A Abukaff… - Plos one, 2022 - journals.plos.org
Introduction There is inadequate evidence to recommend the use of any traditional and
complementary medicine (T&CM) methods such as vitamin, mineral, herbal or other dietary …

[HTML][HTML] A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients

S Kumar, SS Eranezhath, VK Vishwanathan… - Journal of Herbal …, 2024 - Elsevier
Introduction In hospitalised mild to moderate COVID-19 patients with pre-existing type 2
diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as …

Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological …

S Kumar, K Ramaraju, MS Kakarla, SS Eranezhath… - Cureus, 2024 - pmc.ncbi.nlm.nih.gov
Background Effective management of both acute and post-acute sequelae of SARS-CoV-2
is essential, particularly for type 2 diabetes mellitus (T2DM) patients, who are at increased …

Yoga and Other Alternative Therapies to Fight Against COVID-19 Effectively: A Systematic Review of Randomized Controlled Trials

P Tyagi, K Jain, IV Basavaraddi - Indian Journal of Physical …, 2024 - journals.lww.com
The COVID-19 pandemic had an immense impact on the world, affecting millions of people
and prompting medical professionals to work tirelessly to save lives. In addition to …

Letter to Editor on" A randomized, controlled, blinded, parallel-group, clinical trial to study the role of Ayurcov (AyurCoro3), a one-day regimen as an adjuvant therapy …

BK Khuntia, A Agarwal, G Sharma - Complementary Therapies in …, 2022 - ncbi.nlm.nih.gov
Dear Editor, We read with interest the article by Sankhe et al. 1 on the role of Ayurcov
(AyurCoro3), a one-day regimen as adjuvant therapy for COVID-19 disease management …

[PDF][PDF] Journal of Herbal Medicine

S Kumar, SS Eranezhath, VK Vishwanathan… - researchgate.net
Introduction: In hospitalised mild to moderate COVID-19 patients with pre-existing type 2
diabetes, we evaluated the efficacy of add-on customised Ayurveda intervention as …